Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Aeroflot reissued 18 aircraft of Irish AerCap into Russian ownership

9/6/23 AFLT

Sual Partners filed a lawsuit against Rusal's Board of Directors

9/6/23 RUAL

Cosmos Hotel became the owner of the hotel construction project in Pskov

9/6/23 AFKS

OGK-2 plans additional issue of 48.28 bln shares

9/6/23 OGKB

UWC will conduct additional share issue to reduce debt

9/5/23 UWGN

Moscow Exchange is negotiating the issuance of an Islamic equivalent of bonds

9/5/23 MOEX

UWC to increase railcar output by 2.1 times

9/5/23 UWGN

EMC shareholders approved the redomiciliation

9/5/23 GEMC

European Electrotechnics updated its dividend policy

9/5/23 EELT

VK ID monthly active audience reached 91 mln users

9/5/23 VKCO